InsidersTradesSigma
Follow the 티앤엘 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 티앤엘 has recorded 1 insider filings. Market capitalisation: €461.8bn. The latest transaction was reported on 9 April 2026 (Other). Among the most active insiders: 최윤소. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
티앤엘 是一家在 XKRX 市场上市的健康和制药公司。它专注于为患者的福祉和健康开发创新解决方案。